Viva Biotech Holdings (VBIZF)
OTCMKTS · Delayed Price · Currency is USD
0.2270
-0.0723 (-24.16%)
At close: Apr 14, 2025

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
Contract Development Manufacture Organisation and Commercialisation
1.45B
Log In
Log In
Log In
Log In
Upgrade
Contract Development Manufacture Organisation and Commercialisation Growth
-16.11%
Log In
Log In
Log In
Log In
Upgrade
Drug Discovery
933.59M
Log In
Log In
Log In
Log In
Upgrade
Drug Discovery Growth
-10.30%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
United States
898.13M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-15.67%
Log In
Log In
Log In
Log In
Upgrade
European Union
651.46M
Log In
Log In
Log In
Log In
Upgrade
European Union Growth
10.18%
Log In
Log In
Log In
Log In
Upgrade
China
357.66M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-19.57%
Log In
Log In
Log In
Log In
Upgrade
Other Asian Countries
321.99M
Log In
Log In
Log In
Log In
Upgrade
Other Asian Countries Growth
-29.51%
Log In
Log In
Log In
Log In
Upgrade
Other Countries/Regions
102.92M
Log In
Log In
Log In
Log In
Upgrade
Other Countries/Regions Growth
-23.45%
Log In
Log In
Log In
Log In
Upgrade
Africa
49.76M
Log In
Log In
Log In
Log In
Upgrade
Africa Growth
-33.71%
Log In
Log In
Log In
Log In
Upgrade